Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2017

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Midazolam (Epistatus®) has been accepted for use in the treatment of prolonged, acute, convulsive seizures in children and adolescents aged 10 to less than 18 years. This product provides a licensed alternative to unlicensed preparations.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2017' on Email Share 'SMC Update - November 2017' on Delicious Share 'SMC Update - November 2017' on Digg Share 'SMC Update - November 2017' on Facebook Share 'SMC Update - November 2017' on Google+ Share 'SMC Update - November 2017' on reddit Share 'SMC Update - November 2017' on StumbleUpon Share 'SMC Update - November 2017' on Twitter

atomic-wealth

No Comments to “SMC Update - November 2017”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer